Form 4: Community Health Systems EVP David Rice Receives Equity

EVP-Clinical Operations & CMO David V. Rice was granted 30,000 shares of restricted stock and 30,000 stock options as part of a compensation package.

Summary

• David V. Rice, EVP-Clinical Operations & CMO of Community Health Systems, received an equity grant on June 1, 2026.
• The grant includes 30,000 shares of time-vesting restricted stock.
• The grant includes 30,000 performance-based restricted stock units.
• The grant includes 30,000 stock options with an exercise price of $2.75 per share.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine regulatory disclosure regarding executive compensation, which is neutral in terms of immediate market impact.

Positives

• Alignment of executive interests with long-term shareholder value through performance-based equity.
• Incentivizes management to achieve specific EBITDA and revenue growth targets through 2028.

Negatives

• Potential for future shareholder dilution upon the exercise of stock options and vesting of restricted shares.

Risks

• Performance-based shares are subject to market and operational risks, with vesting dependent on achieving specific growth targets.
• Stock options are subject to market price volatility, which may impact their ultimate value.

Future Outlook

The executive's compensation is tied to achieving cumulative same-store adjusted EBITDA growth and cumulative same-store net revenue growth targets over the 2026-2028 period.

Management Comments

• The performance-based shares vest between 0% and 200% based on the level of achievement of predetermined growth objectives.

Industry Context

StockSavvy.ai notes that this filing reflects standard executive compensation practices in the healthcare sector, where equity-based incentives are used to retain key clinical leadership and drive operational performance metrics.

Comparison to Industry Standards

• The use of performance-based restricted stock units (PSUs) tied to EBITDA and revenue growth is consistent with industry benchmarks for large-cap healthcare providers.
• Vesting schedules of 1/3 per year for time-based awards align with standard corporate governance practices for executive retention.

Stakeholder Impact

• Shareholders may experience minor dilution upon the eventual exercise or vesting of these equity awards.

Next Steps

• Vesting of time-based restricted stock and options beginning June 1, 2027.
• Evaluation of performance targets at the conclusion of the 2026-2028 performance period.

Key Dates

Keywords

Community Health Systems, CYH, Executive Compensation, Form 4, Insider Trading, Equity Grant